表紙
市場調查報告書

腫瘤學資訊學的全球市場 - 競爭情形、產品、終端用戶、地區的引進:分析與預測 (2019-2025年)

Global Oncology Informatics Market: Focus on Competitive Landscape, Products, End Users, Regional Adoption - Analysis and Forecast, 2019-2025

出版商 BIS Research Inc. 商品編碼 920947
出版日期 內容資訊 英文 271 Pages
商品交期: 最快1-2個工作天內
價格
腫瘤學資訊學的全球市場 - 競爭情形、產品、終端用戶、地區的引進:分析與預測 (2019-2025年) Global Oncology Informatics Market: Focus on Competitive Landscape, Products, End Users, Regional Adoption - Analysis and Forecast, 2019-2025
出版日期: 2019年12月31日內容資訊: 英文 271 Pages
簡介

全球腫瘤學資訊學市場規模在2019年∼2025年間,預測將以7.03%的年複合成長率 (CAGR) 。腫瘤學EHR市場區隔預計將從2018年的21億4,000萬美元,到2025年末達32億4,000萬美元。北美在2018年中,在各地區中構成最大的市場佔有率,其規模預計到2025年末達29億2,000萬美元,在預測期間中預測將以6.02%的年複合成長率成長。可是,亞太地區醫療保健基礎設施的改善,負擔大的健康護理系統,及東南亞國著重醫療旅遊業目的地的形象,該地區也預計有高成長。

本報告涵括全球病患監測解決方案市場,提供市場動態,競爭環境,各市場區隔、各地區的市場,競爭情形,及主要企業等相關的詳細分析。

摘要整理

第1章 產品定義

  • 癌症資訊系統 (OIS)
  • 腫瘤學資訊學使用的其他系統

第2章 市場概要

  • 市場現狀
  • 癌症的EHR所扮演的角色
  • 合併EHR和OIS的必要性
  • EHR癌症系統的定價模式
  • 各定價模式的消費者的選擇

第3章 調查範圍

第4章 調查手法

第5章 產業分析

  • 產業趨勢
  • 法律規範
  • 專利分析

第6章 競爭情形

  • 市場佔有率分析
  • 主要的發展、策略
  • 產品製圖分析

第7章 市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會

第8章 全球腫瘤學資訊學市場:各類型

  • 概要
  • EHR (電子健康記錄)
  • PHR (個人健康記錄)
  • CDSS (臨床診斷決策支援系統)
  • 藥物研發、開發資訊學
  • 影像分析

第9章 全球腫瘤學資訊學市場:各終端用戶

  • 概要
  • 醫藥品產業
  • 生命科學產業
  • CRO (醫藥品臨床研究委外機構)
  • 大學機關、研究中心
  • 其他 (醫院、其他選擇照護)

第10章 全球腫瘤學資訊學市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (RoW)

第9章 企業簡介

  • Cerner Corporation
  • Change Healthcare
  • Elekta AB
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • IBM Corporation
  • Inspirata, Inc.
  • Koninklijke Philips N.V.
  • Laboratory Corporation of America Holdings
  • McKesson Corporation
  • MIM Software, Inc.
  • Oncology Analytics, Inc
  • PerkinElmer, Inc.
  • RELX Group
  • Sirenas, LLC
  • UnitedHealth Group, Inc
  • Varian Medical Systems, Inc
目錄
Product Code: BH075A

"Global Oncology Informatics Market to Grow at a CAGR of 7.03% from 2019-2025."

Key Questions Answered in the Report:

  • How are oncology informatics solutions positioned to save healthcare expenditure annually? How can these solutions help in reducing healthcare expenditure for developed economies such as North America and Europe?
  • How are oncology informatics solutions helping in changing the business model of healthcare delivery?
  • What are the major developments such as product launches, mergers and acquisitions, collaborations, and partnerships taking place in the market, and how are they changing the overall dynamics of the global oncology informatics market?
  • What are the major pricing strategies employed by the vendors that can significantly put pricing pressure on the competitors?
  • What is the current user base for the leading oncology informatics solutions vendors in the market?
  • What are the technological and regional trends pertaining to the global oncology informatics market?
  • What is the growth potential of the global oncology informatics market in North America, Europe, Asia-Pacific, and Rest-of-the-World?

Global Oncology Informatics Market Forecast, 2019-2025

The Global Oncology Informatics Market Report by BIS Research projects the market to grow at a significant CAGR of 7.03% during the forecast period from 2019 to 2025. The market has evolved dramatically with the increasing cost of cancer care, emphasis on reduction in medical errors and readmission rates, growing number of cancer patients, and rising adoption of oncology specific EHRs.

Despite the benefits of these software solutions, the major challenges in the market are lack of shortage of medical oncologists, high upfront cost of installation of these solutions, lack of interoperability within the system, and data security concerns. Some of the major opportunities for the key vendors in the market could be integration of oncology informatics with Blockchain technology, investment opportunities in emerging economies such as India, China, and Brazil, collaboration with precision medicine providers, and introduction of systems in different languages.

Expert Quote

"Pharmaceutical companies and life science companies are the major end users of the oncology informatics market in terms of revenue share. The pharmaceutical companies market share is expected to increase up -to $2.04 billion, while life science companies' share is estimated to be $1.27 billion by the end of 2025. However, the usage of the solutions is expected to increase in hospitals and research centers in order to streamline the workflow of the facilities and improve the quality of care."

Scope of the Market Intelligence on Global Oncology Informatics Market

The purpose of this study is to gain a holistic view of the global oncology informatics market in terms of various influencing factors such as regional adoption trends, product types, and end users.

The scope of this report constitutes of an in-depth study of the global oncology informatics market, including a thorough analysis of the products in the market as well as their adoption spanning different geographical regions. The market has been chiefly segmented into component type, end user, and region. The report provides the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

Market Segmentation

The Global Oncology Informatics Market can be segmented on the basis of ccomponent type, end user, and region. As of 2018, oncology EHRs accounts for $2.14 billion and is expected to reach a value of $3.24 billion by the end of 2025. In terms of growth, the end users' academic institutes and research centers segment is expected to grow at the highest CAGR of 7.69% during the forecast period.

As of 2018, North America is the largest shareholder for the overall market and is expected to reach the value of $2.92 billion by the end of 2025 growing with the CAGR of 6.02% during the forecast period. However, a higher growth rate can be expected from the Asia-Pacific region, considering its improving healthcare infrastructure, overburdened healthcare system, and focus of ASEAN countries to be recognized as medical tourism destination.

Although the adoption rate of the oncology informatics solutions has been moderate, the potential that lies in them is immense. The integration of oncology informatics solutions in the healthcare facility will not only improve customer experience but also help hospitals to provide improved quality of healthcare. To make the entire oncology healthcare system more efficient, the oncology solutions can be integrated across various stakeholders, namely pharmaceutical companies, life science companies, contract research organizations (CROs), academic institutes and research centers, and hospitals and diagnostics laboratories.

Key Companies in the Global Oncology Informatics Market

Some of the major key players in the global oncology informatics market include Cerner Corporation, Change Healthcare, Elekta AB, F.Hoffmann-La Roche Ltd., Hologic Inc., IBM Corporation, Inspirata Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, McKesson Corporation, MIM Software, Inc. Oncology Analytics, Inc. , PerkinElmer, Inc., RELX Group, Sirenas LLC, UnitedHealth Group, Inc. , and Varian Medical Systems, Inc.

Table of Contents

Executive Summary

1 Product Definition

  • 1.1 Oncology Information System (OIS)
  • 1.2 Other Systems Used in Oncology Informatics

2 Market Overview

  • 2.1 Current Market Scenario
  • 2.2 The Role of EHRs in Oncology
  • 2.3 Need for Integration of EHR and OIS
  • 2.4 Pricing Models for EHR Oncology Systems
  • 2.5 Consumer Preference for Different Pricing Models

3 Scope of the Report

4 Research Methodology

  • 4.1 Research Methodology

5 Industry Analysis

  • 5.1 Industry Trends
  • 5.2 Regulatory Framework
    • 5.2.1 Regulatory Framework in North America
    • 5.2.2 Regulatory Framework in Europe
    • 5.2.3 Regulatory Framework in Asia-Pacific
  • 5.3 Patent Analysis

6 Competitive Landscape

  • 6.1 Market Share Analysis
  • 6.2 Key Developments and Strategies
    • 6.2.1 Partnerships and Collaborations
    • 6.2.2 Product Launches and Upgradations
    • 6.2.3 Mergers and Acquisitions
    • 6.2.4 Business Expansion
    • 6.2.5 Others
  • 6.3 Product Mapping Analysis

7 Market Dynamics

  • 7.1 Market Drivers
    • 7.1.1 Increasing Cost of Cancer Care
    • 7.1.2 Emphasis on Reduction in Medical Errors and Readmission Rates
    • 7.1.3 Growing Number of Cancer Patients
    • 7.1.4 Rising Adoption of Oncology-Specific EHRs
  • 7.2 Market Restraints
    • 7.2.1 Shortage of Medical Oncologists
    • 7.2.2 High Cost of Implementation of Oncology-Specific EMRs
    • 7.2.3 Lack of Interoperability Among HIT Systems
    • 7.2.4 Data Security Concerns
  • 7.3 Market Opportunities
    • 7.3.1 Integration of Oncology Health Informatics with Blockchain
    • 7.3.2 Investment Opportunities in Emerging Markets such as India, China, and Brazil
    • 7.3.3 Collaborations with Precision Medicine Providers
    • 7.3.4 Introduction of Solutions in Different Languages

8 Global Oncology Informatics Market (by Type)

  • 8.1 Overview
  • 8.2 Electronic Health Records (EHRs)
    • 8.2.1 Overview
    • 8.2.2 Role of HER in Oncology
    • 8.2.3 Features of Oncology HER
    • 8.2.4 Oncology HER: Product Description
    • 8.2.5 Global Installation of Oncology HER
  • 8.3 Population Health Management (PHM)
    • 8.3.1 Overview
    • 8.3.2 Role of PHM in Oncology
    • 8.3.3 Features of Oncology PHM
    • 8.3.4 Oncology PHM: Product Description
  • 8.4 Clinical Decision Support System (CDSS)
    • 8.4.1 Overview
    • 8.4.2 Role of CDSS in Oncology
    • 8.4.3 Features of Oncology CDSS
    • 8.4.4 Oncology CDSS: Product Description
    • 8.4.5 Application of CDSS in Oncology
    • 8.4.6 Global Installation of Oncology CDSS
  • 8.5 Drug Discovery and Development Informatics
    • 8.5.1 Overview
    • 8.5.2 Role of Drug Discovery and Development Informatics in Oncology
    • 8.5.3 Drug Discovery and Development Informatics in Oncology: Product Description
    • 8.5.4 Application of Drug Discovery and Development Informatics in Oncology
    • 8.5.5 Global Installation of Oncology Drug Discovery and Development Informatics
  • 8.6 Image Analytics
    • 8.6.1 Overview
    • 8.6.2 Role and Benefits of Image Analytics in Oncology
    • 8.6.3 Oncology Image Analytics: Product Description
    • 8.6.4 Application of Image Analytics in Oncology

9 Global Oncology Informatics Market (by End User)

  • 9.1 Overview
  • 9.2 Pharmaceutical Industry
  • 9.3 Life Science Industry
  • 9.4 Contract Research Organizations (CROs)
  • 9.5 Academic Institutes and Research Centers
  • 9.6 Others (Hospitals and Other Care Facilities)

10 Global Oncology Informatics Market (by Region)

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 U.S.
      • 10.2.1.1 Companies in the U.S. Oncology Informatics Market
      • 10.2.1.2 Government Initiatives
      • 10.2.1.3 CDSS in the U.S. Oncology Informatics Market
      • 10.2.1.4 Market Dynamics
    • 10.2.2 Canada
      • 10.2.2.1 Degree of Adoption of EHRs
      • 10.2.2.2 Local Oncology Informatics Products
      • 10.2.2.3 Market Dynamics
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Degree of Adoption of HIT Solutions
      • 10.3.1.2 Factors Impacting Oncology Informatics Market in Germany
      • 10.3.1.3 Market Dynamics
    • 10.3.2 U.K.
      • 10.3.2.1 Degree of Adoption of Oncology Informatics
      • 10.3.2.2 Market Dynamics
    • 10.3.3 France
      • 10.3.3.1 Degree of Adoption of HER
      • 10.3.3.2 Status of Oncology Informatics
      • 10.3.3.3 Market Dynamics
    • 10.3.4 Spain
      • 10.3.4.1 Degree of Adoption of Oncology Informatics
      • 10.3.4.2 Market Dynamics
    • 10.3.5 Italy
      • 10.3.5.1 Degree of Adoption of HIT Solutions
      • 10.3.5.2 Factors Impacting Oncology Informatics Market in Italy
      • 10.3.5.3 Partnerships
      • 10.3.5.4 Market Dynamics
    • 10.3.6 Rest-of-Europe
  • 10.4 Asia-Pacific
    • 10.4.1 South Korea
      • 10.4.1.1 Degree of Adoption of HIT Solutions
      • 10.4.1.2 Oncology Informatics in South Korea
      • 10.4.1.3 Market Dynamics
    • 10.4.2 Japan
      • 10.4.2.1 Degree of Adoption of HIT Solutions
      • 10.4.2.2 Implementation of Oncology Informatics
      • 10.4.2.3 Market Dynamics
    • 10.4.3 China
      • 10.4.3.1 Degree of Adoption of HIT Solutions
      • 10.4.3.2 Partnerships
      • 10.4.3.3 Market Dynamics
    • 10.4.4 India
      • 10.4.4.1 Degree of Adoption of HIT Solutions
      • 10.4.4.2 Initiatives for Oncology Informatics
      • 10.4.4.3 Market Dynamics
    • 10.4.5 Australia
      • 10.4.5.1 Degree of Adoption of HER
      • 10.4.5.2 Market Dynamics
    • 10.4.6 Rest-of-Asia-Pacific
      • 10.4.6.1 Degree of Adoption of HIT Solutions in New Zealand
      • 10.4.6.2 Degree of Adoption of HIT Solutions in Malaysia
      • 10.4.6.3 Degree of Adoption of HIT Solutions in Singapore
      • 10.4.6.4 Market Dynamics
  • 10.5 Rest-of-the-World
    • 10.5.1 U.A.E.
      • 10.5.1.1 Degree of Adoption of HIT Solutions
      • 10.5.1.2 Challenges
      • 10.5.1.3 Market Dynamics
    • 10.5.2 Saudi Arabia
      • 10.5.2.1 Degree of Adoption of HIT Solutions
      • 10.5.2.2 Market Opportunities
    • 10.5.3 Brazil
    • 10.5.4 Mexico
    • 10.5.5 South Africa
    • 10.5.6 Rest-of-Rest-of-the-World

11 Company Profiles

  • 11.1 Cerner Corporation
    • 11.1.1 Company Overview
    • 11.1.2 Role of Cerner Corporation in Global Oncology Informatics Market
    • 11.1.3 Product Offerings
    • 11.1.4 Financials
    • 11.1.5 Key Insights about Financial Health of the Company
    • 11.1.6 Recent Developments
    • 11.1.7 SWOT Analysis
  • 11.2 Change Healthcare
    • 11.2.1 Company Overview
    • 11.2.2 Role of Change Healthcare in Global Oncology Informatics Market
    • 11.2.3 Product Offerings
    • 11.2.4 Recent Key Developments
    • 11.2.5 SWOT Analysis
  • 11.3 Elekta AB
    • 11.3.1 Company Overview
    • 11.3.2 Role of Elekta AB in Global Oncology Informatics Market
    • 11.3.3 Product Offerings
    • 11.3.4 Financials
    • 11.3.5 Key Insights about Financial Health of the Company
    • 11.3.6 Recent Key Developments
    • 11.3.7 SWOT Analysis
  • 11.4 F. Hoffmann-La Roche Ltd
    • 11.4.1 Company Overview
    • 11.4.2 Role of F. Hoffmann-La Roche Ltd in Global Oncology Informatics Market
    • 11.4.3 Product Offering
    • 11.4.4 Financials
    • 11.4.5 Key Insights about Financial Health of the Company
    • 11.4.6 Recent Developments
    • 11.4.7 SWOT Analysis
  • 11.5 Hologic, Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Role of Hologic, Inc. in Global Oncology Informatics Market
    • 11.5.3 Product Offerings
    • 11.5.4 Financials
    • 11.5.5 Key Insights about Financial Health of the Company
    • 11.5.6 Recent Developments
    • 11.5.7 SWOT Analysis
  • 11.6 IBM Corporation
    • 11.6.1 Company Overview
    • 11.6.2 Role of IBM Corporation in Global Oncology Informatics Market
    • 11.6.3 Product Offerings
    • 11.6.4 Financials
    • 11.6.5 Key Insights about Financial Health of the Company
    • 11.6.6 Recent Developments
    • 11.6.7 SWOT Analysis
  • 11.7 Inspirata, Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Role of Inspirata, Inc. in Global Oncology Informatics Market
    • 11.7.3 Product Offerings
    • 11.7.4 Recent Key Developments
    • 11.7.5 SWOT Analysis
  • 11.8 Koninklijke Philips N.V.
    • 11.8.1 Company Overview
    • 11.8.2 Role of Koninklijke Philips N.V. in Global Oncology Informatics Market
    • 11.8.3 Product Offerings
    • 11.8.4 Financials
    • 11.8.5 Key Insights about Financial Health of the Company
    • 11.8.6 Recent Developments
    • 11.8.7 SWOT Analysis
  • 11.9 Laboratory Corporation of America Holdings
    • 11.9.1 Company Overview
    • 11.9.2 Role of Laboratory Corporation of America Holdings in Global Oncology Informatics Market
    • 11.9.3 Product Offerings
    • 11.9.4 Financials
    • 11.9.5 Recent Key Developments
    • 11.9.6 SWOT Analysis
  • 11.10 McKesson Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Role of McKesson Corporation in Global Oncology Informatics Market
    • 11.10.3 Product Offerings
    • 11.10.4 Financials
    • 11.10.5 Key Insights about Financial Health of the Company
    • 11.10.6 Recent Development
    • 11.10.7 SWOT Analysis
  • 11.11 MIM Software, Inc.
    • 11.11.1 Company Overview
    • 11.11.2 Role of MIM Software, Inc. in Global Oncology Informatics Market
    • 11.11.3 Product Offerings
    • 11.11.4 Recent Key Developments
    • 11.11.5 SWOT Analysis
  • 11.12 Oncology Analytics, Inc
    • 11.12.1 Company Overview
    • 11.12.2 Role of Oncology Analytics, Inc.in Global Oncology Informatics Market
    • 11.12.3 Product Offerings
    • 11.12.4 Recent Developments
    • 11.12.5 SWOT Analysis
  • 11.13 PerkinElmer, Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Role of PerkinElmer Inc, in Global Oncology Informatics Market
    • 11.13.3 Product Offerings
    • 11.13.4 Financials
    • 11.13.5 Key Insights about Financial Health of the Company
    • 11.13.6 Recent Developments
    • 11.13.7 SWOT Analysis
  • 11.14 RELX Group
    • 11.14.1 Company Overview
    • 11.14.2 Role of RELX Group in Global Oncology Informatics Market
    • 11.14.3 Product Offerings
    • 11.14.4 Financials
    • 11.14.5 Recent Developments
    • 11.14.6 SWOT Analysis
  • 11.15 Sirenas, LLC
    • 11.15.1 Company Overview
    • 11.15.2 Role of Sirenas, LLC in Global Oncology Informatics Market
    • 11.15.3 Product Offerings
    • 11.15.4 Recent Key Developments
    • 11.15.5 SWOT Analysis
  • 11.16 UnitedHealth Group, Inc
    • 11.16.1 Company Overview
    • 11.16.2 Role of UnitedHealth Group, Inc in Global Oncology Informatics Market
    • 11.16.3 Product Offerings for Oncology Informatics Market
    • 11.16.4 Financials
    • 11.16.5 Recent Developments
    • 11.16.6 SWOT Analysis
  • 11.17 Varian Medical Systems, Inc
    • 11.17.1 Company Overview
    • 11.17.2 Role of Varian Medical Systems, Inc. in Global Oncology Informatics Market
    • 11.17.3 Product Offerings
    • 11.17.4 Financials
    • 11.17.5 Key Insights about Financial Health of the Company
    • 11.17.6 Recent Developments
    • 11.17.7 SWOT Analysis

List of Tables

  • Table 1: Products for End Users as per Area of Usage
  • Table 2: Market Share of Different End Users, 2018 & 2025
  • Table 2.1: HER Systems Meeting ASCO-Defined Criteria
  • Table 2.2: Comparison Between Different HER Pricing Models
  • Table 2.3: Pricing of Different Medical Oncology EHRs for Different Practice Sizes
  • Table 5.1: Regulatory Framework/Act/Policy/Consortium/Standard for Oncology Informatics Market in North America
  • Table 5.2: Regulatory Framework/Act/Policy/Consortium/Standard for Oncology Informatics Market in Europe
  • Table 5.3: Regulatory Framework/Act/Policy/Consortium/Standard for Oncology Informatics Market in Asia-Pacific
  • Table 5.4: Number of Patents Granted Across Different Regions
  • Table 6.1: Partnerships and Collaborations, 2017-2019
  • Table 6.2: Product Launches and Upgradations, 2017-2019
  • Table 6.3: Mergers and Acquisitions, 2017-2019
  • Table 6.4: Business Expansion, 2016-2019
  • Table 6.5: Awards/Certifications/Funding/Approvals, 2017-2019
  • Table 6.6: Providers of Oncology Informatics Products
  • Table 7.1: Country-Wise Analysis of Adverse Events, 2016
  • Table 8.1: Description of Various Oncology HER
  • Table 8.2: Global Installation of Oncology HER in Leading Organizations
  • Table 8.3: Oncology PHM and its Product Description
  • Table 8.4: Oncology CDSS, Product Description
  • Table 8.5: Application Areas of CDSS in Oncology
  • Table 8.6: Global Installation of Oncology CDSS in Leading Organizations
  • Table 8.7: Oncology Drug Discovery and Development Informatics and Product Description
  • Table 8.8: Global Installation of Oncology Drug Discovery and Development in Leading Organizations
  • Table 8.9: Oncology Image Analytics and Product Description
  • Table 10.1: Adoption Rate of HER Across Specialties in the U.S. Healthcare System, 2017
  • Table 10.2: Other European Countries Market Share in 2018 and 2025
  • Table 10.3: Presence of HER and EMR Systems Across Different Private and Public Hospitals
  • Table 11.1: Recent Developments: Cerner Corporation
  • Table 11.2: Recent Developments: Change Healthcare Corporation
  • Table 11.3: Recent Developments: Elekta AB
  • Table 11.4: Recent Developments, F. Hoffmann- La Roche Ltd
  • Table 11.5: Recent Developments: Hologic, Inc.
  • Table 11.6: Recent Developments: IBM Corporation
  • Table 11.7: Recent Developments: Inspirata, Inc.
  • Table 11.8: Recent Developments: Koninklijke Philips N.V.
  • Table 11.9: Recent Developments: Laboratory Corporation of America Holdings
  • Table 11.10: Recent Developments: McKesson Corporation
  • Table 11.11: Recent Developments, MIM Software, Inc.
  • Table 11.12: Recent Developments: Oncology Analytics, Inc.
  • Table 11.13: Recent Developments: PerkinElmer, Inc.
  • Table 11.14: Recent Developments: RELX Group
  • Table 11.15: Recent Developments: Sirenas, LLC
  • Table 11.16: Recent Developments: United Health Group, Inc.
  • Table 11.17: Recent Developments: Varian Medical Systems, Inc.

List of Figures

  • Figure 1: Global Oncology Informatics Market, 2018-2025
  • Figure 2: Market Dynamics
  • Figure 3: Share of Different Strategies
  • Figure 4: Market Share of Different Regions, 2019-2025
  • Figure 2.1: Comparison of Direct Cost Between SaaS and On-Premise-Based Systems
  • Figure 2.2: Comparison of Subscription License and Perpetual License Fee Structure
  • Figure 3.1: Global Oncology Informatics Market: Market Segmentation
  • Figure 4.1: Global Oncology Informatics Market Methodology
  • Figure 4.2: Primary Research
  • Figure 4.3: Secondary Research
  • Figure 4.4: Data Triangulation
  • Figure 4.5: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 4.6: Assumptions and Limitations
  • Figure 4.7: Factors Considered for Data Prediction and Modeling
  • Figure 5.1: Advantages of Oncology Informatics
  • Figure 6.1: Global Oncology Informatics Market Share (by Company)
  • Figure 6.2: Global Oncology Informatics Market (Key development and strategies)
  • Figure 6.3: Partnerships and Collaborations Share (by Company)
  • Figure 6.4: Product Launches and Upgradations (by Company)
  • Figure 6.5: Mergers and Acquisitions (by Company)
  • Figure 6.6: Other Activities (Share)
  • Figure 6.7: Product Mapping Analysis- Global Oncology Informatics Market
  • Figure 8.1: Global Oncology Informatics Market, by Type
  • Figure 8.2: Global Oncology HER Market, 2018-2025
  • Figure 8.3: Features of Oncology HER
  • Figure 8.4: Investment Plans of Healthcare Providers and Payers for Population Health Management Strategies
  • Figure 8.5: Workflow of Population Health Management Strategy
  • Figure 8.6: Global Oncology PHM Market, 2018-2025
  • Figure 8.7: Features of Oncology PHM
  • Figure 8.8: Workflow of CDSS in Clinical Setting
  • Figure 8.9: Global Oncology CDSS Market, 2018-2025
  • Figure 8.10: Features of Oncology CDSS
  • Figure 8.11: Global Oncology Drug Discovery and Development Informatics Market, 2018-2025
  • Figure 8.12: Global Oncology Image Analytics Market, 2018-2025
  • Figure 9.1: End Users of Oncology Informatics Market
  • Figure 9.2: Global Oncology Informatics Market (Pharmaceutical Industry), 2018-2025
  • Figure 9.3: Global Oncology Informatics Market (Life Science Industry), 2018-2025
  • Figure 9.4: Global Oncology Informatics Market (CROs), 2018-2025
  • Figure 9.5: Global Oncology Informatics Market (Academic Institutes and Research Centers), 2018-2025
  • Figure 9.6: Global Oncology Informatics Market (Hospitals and Other Care Facilities), 2018-2025
  • Figure 10.1: Region-Wise Analysis of Global Oncology Informatics Market, 2018 and 2025
  • Figure 10.2: North America Oncology Informatics Market, 2018-2025
  • Figure 10.3: Factors Influencing North America Oncology Informatics Market
  • Figure 10.4: U.S. Oncology Informatics Market, 2018-2025
  • Figure 10.5: Canada Oncology Informatics Market, 2018-2025
  • Figure 10.6: Prevalence Rate of Various Chronic Diseases in Canada
  • Figure 10.7: Europe Oncology Informatics Market, 2018-2025
  • Figure 10.8: Initiatives in Europe
  • Figure 10.9: Factors Influencing Oncology Informatics in Europe
  • Figure 10.10: Germany Oncology Informatics Market, 2018-2025
  • Figure 10.11: Cancer Cases in Germany, by Type, 2018
  • Figure 10.12: Distribution of Medical Treatment Errors in Germany, by Error Type, 2016,
  • Figure 10.13: U.K. Oncology Informatics Market, 2018-2025
  • Figure 10.14: Cancer Cases in U.K., by Type, 2018
  • Figure 10.15: France Oncology Informatics Market, 2018-2025
  • Figure 10.16: Cancer Cases in France, by Type
  • Figure 10.17: Spain Oncology Informatics Market, 2018-2025
  • Figure 10.18: Cancer Cases in Spain, by Type, 2018
  • Figure 10.19: Italy Oncology Informatics Market, 2018-2025
  • Figure 10.20: Cancer Cases in Italy, by Type, 2018
  • Figure 10.21: Other European Countries Oncology Informatics Market, 2018-2025
  • Figure 10.22: Asia-Pacific Oncology Informatics Market, 2018-2025
  • Figure 10.23: Factors Influencing Oncology Informatics Market in Asia-Pacific
  • Figure 10.24: South Korea Oncology Informatics Market, 2018-2025
  • Figure 10.25: Japan Oncology Informatics Marker, 2018-2025
  • Figure 10.26: China Oncology Informatics Marker, 2018-2025
  • Figure 10.27: India Oncology Informatics Market, 2018-2025
  • Figure 10.28: Australia Oncology Informatics Market, 2018-2025
  • Figure 10.29: Other Asia-Pacific Countries Oncology Informatics Marker, 2018-2025
  • Figure 10.30: Rest-of-the-World Oncology Informatics Market, 2018-2025
  • Figure 10.31: Factors Influencing the Rest-of-the-World Oncology Informatics Market
  • Figure 10.32: U.A.E. Oncology Informatics Market, 2018-2025
  • Figure 10.33: Saudi Arabia Oncology Informatics Market, 2018-2025
  • Figure 10.34: Brazil Oncology Informatics Market, 2018-2025
  • Figure 10.35: Mexico Oncology Informatics Market, 2018-2025
  • Figure 10.36: South Africa Oncology Informatics Market, 2018-2025
  • Figure 10.37: Rest-of-rest-of-the-World Oncology Informatics Market, 2018-2025
  • Figure 11.1: Cerner Corporation: Product Portfolio for Oncology Informatics Market
  • Figure 11.2: Cerner Corporation: Overall Financials, 2016-2018
  • Figure 11.3: Cerner Corporation.: Revenue (by Segment), 2016-2018
  • Figure 11.4: Cerner Corporation.: Revenue (by Region), 2016-2018
  • Figure 11.5: Cerner Corporation: R&D Expenditure, 2016-2018
  • Figure 11.6: Change Healthcare: Product Portfolio for Oncology Informatics Market
  • Figure 11.7: Elekta AB: Product Portfolio for Oncology Informatics Market
  • Figure 11.8: Elekta AB: Overall Financials ,2016-2018
  • Figure 11.9: Elekta AB: Revenue (by Segment) ,2016-2018
  • Figure 11.10: Elekta AB: Revenue (by Region) ,2016-2018
  • Figure 11.11: Elekta AB: R&D Expenditure, 2016-2018
  • Figure 11.12: F. Hoffmann-La Roche Ltd: Product Portfolio for Oncology Informatics Market
  • Figure 11.13: F. Hoffmann-La Roche Ltd: Overall Financials, 2016-2018
  • Figure 11.14: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2016-2018
  • Figure 11.15: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2017-2018
  • Figure 11.16: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2016
  • Figure 11.17: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2016-2018
  • Figure 11.18: Hologic, Inc.: Product Portfolio for Oncology Informatics Market
  • Figure 11.19: Hologic, Inc.: Overall Financials ,2017-2019
  • Figure 11.20: Hologic, Inc.: Revenue (by Business Segment) ,2017-2019
  • Figure 11.21: Hologic, Inc.: Revenue (by Region) ,2017-2019
  • Figure 11.22: Hologic, Inc.: R&D Expenditure, 2017-2019
  • Figure 11.23: IBM Corporation: Product Portfolio for Oncology Informatics Market
  • Figure 11.24: IBM Corporation: Overall Financials ,2016-2018
  • Figure 11.25: IBM Corporation: Revenue (by Business Segment) ,2016-2018
  • Figure 11.26: IBM Corporation: Revenue (by Region) ,2016-2018
  • Figure 11.27: IBM Corporation: R&D Expenditure, 2016-2018
  • Figure 11.28: Inspirata, Inc.: Product Portfolio for Oncology Informatics Market
  • Figure 11.29: Koninklijke Philips N.V.: Product Portfolio for Oncology Informatics Market
  • Figure 11.30: Koninklijke Philips N.V.: Overall Financials, 2016-2018
  • Figure 11.31: Koninklijke Philips N.V.: Revenue (by Segment), 2016-2018
  • Figure 11.32: Koninklijke Philips N.V.: Revenue (by Region), 2016-2018
  • Figure 11.33: Koninklijke Philips N.V.: R&D Expenditure, 2016-2018
  • Figure 11.34: Laboratory Corporation of America Holdings: Product Portfolio for Oncology Informatics Market
  • Figure 11.35: Laboratory Corporation of America Holdings: Overall Financials ,2016-2018
  • Figure 11.36: Laboratory Corporation of America Holdings: Revenue (by Segment) ,2016-2018
  • Figure 11.37: Laboratory Corporation of America Holdings: Revenue (by Region) , 2016-2018
  • Figure 11.38: McKesson Corporation: Product Portfolio for Oncology Informatics Market
  • Figure 11.39: McKesson Corporation: Overall Financials, 2016-2018
  • Figure 11.40: McKesson Corporation: Revenue (by Segment), 2016-2018
  • Figure 11.41: McKesson Corporation: Revenue (by Region), 2016-2018
  • Figure 11.42: McKesson Corporation: R&D Expenditure, 2016-2018
  • Figure 11.43: MIM Software, Inc.: Product Portfolio for Oncology Informatics Market
  • Figure 11.44: Oncology Analytics, Inc.: Product Portfolio for Oncology Informatics Market
  • Figure 11.45: PerkinElmer, Inc.: Product Portfolio for Oncology Informatics Market
  • Figure 11.46: PerkinElmer, Inc.: Overall Financials, 2016-2018
  • Figure 11.47: PerkinElmer, Inc.: Revenue (by Segment), 2016-2018
  • Figure 11.48: PerkinElmer, Inc.: Revenue (by Region), 2016-2017
  • Figure 11.49: PerkinElmer, Inc.: Revenue (by Region), 2018
  • Figure 11.50: PerkinElmer, Inc.: R&D Expenditure, 2016-2018
  • Figure 11.51: RELX Group: Product Portfolio for Oncology Informatics Market
  • Figure 11.52: RELX Group: Overall Financials, 2016-2018
  • Figure 11.53: RELX Group: Revenue (by Segment), 2016-2018
  • Figure 11.54: RELX Group: Revenue (by Region), 2016-2018
  • Figure 11.55: Sirenas, LLC: Product Portfolio for Oncology Informatics Market
  • Figure 11.56: UnitedHealth Group Inc: Product Portfolio for Oncology Informatics Market
  • Figure 11.57: UnitedHealth Group, Inc.: Overall Financials, 2016-2018
  • Figure 11.58: UnitedHealth Group, Inc.: Revenue (by Segment), 2016-2018
  • Figure 11.59: United Health Group, Inc.: Revenue (by Region), 2016-2018
  • Figure 11.60: Varian Medical Systems, Inc.: Product Portfolio for Oncology Informatics Market
  • Figure 11.61: Varian Medical Systems, Inc.: Overall Financials, 2016-2018
  • Figure 11.62: Varian Medical Systems, Inc.: Revenue (by Segment), 2016-2018
  • Figure 11.63: Varian Medical Systems, Inc.: Revenue (by Region), 2016-2018
  • Figure 11.64: Varian Medical Systems, Inc.: R&D Expenditure, 2016-2018